Publications by authors named "Phillip B Murray"

Claim this Profile
I
Integrated genomic characterization of IDH1-mutant glioma malignant progression.
Hanwen Bai, Akdes Serin Harmancı, E Zeynep Erson-Omay, Jie Li, Süleyman Coşkun, Phillip B Murray

Nat Genet· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions.
Andrey V Reshetnyak, Phillip B Murray, Xiarong Shi, Elizabeth S Mo, Jyotidarsini Mohanty

Proc Natl Acad Sci U S A· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK.
Phillip B Murray, Irit Lax, Andrey Reshetnyak, Gwenda F Ligon, Jay S Lillquist

Sci Signal· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain malformations associated with Knobloch syndrome--review of literature, expanding clinical spectrum, and identification of novel mutations.
Ahmet Okay Caglayan, Jacob F Baranoski, Fesih Aktar, Wengi Han, Beyhan Tuysuz, Phillip B Murray

Pediatr Neurol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Victoria E Clark, E Zeynep Erson-Omay, Akdes Serin, Jun Yin, Justin Cotney, Phillip B Murray

Science· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis